Drug Development and Delivery recently published an article showcasing Portal Instruments’ transformative needle-free drug delivery system and its partnership strategy.

To view the article, click here.

DOWNLOAD THE PDF

About Portal Instruments

Portal Instruments is a Series B funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. Portal Instruments’ Quality Management System is ISO 13485 certified. For more information, please visit www.portalinstruments.com or follow @portalcambridge on Twitter.

About Drug Development & Delivery

Drug Development & Delivery is a print, online and event provider committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development. The organization reports on formulation development, bioavailability, drug devices, drug delivery technologies, combination products, contract services, API manufacturing, life cycle management, business development, partnerships, collaborations and more. Learn more at drug-dev.com.

Pages of the Portal Instruments website may contain links to third party websites that are not under the control of Portal Instruments. Portal Instruments is not responsible for the content of any such site and the inclusion of these links does not imply the endorsement of the content of the linked site by Portal Instruments.